Patent ID: 7176201

Claim:
A pharmaceutical composition comprising a pharmaceutically acceptable carrier and a compound of the formula: wherein X is O or S; Q is O or S; n is an integer from 1 to 5; R 1 and R 2 are independently selected from the group consisting of H, substituted or unsubstituted straight or branched alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted at least partially saturated cycloalkyl, and substituted or unsubstituted cycloheteroalkyl, with the proviso that R 1 and R 1 are not both hydrogen, wherein each Ra member is independently selected from the group consisting of unsubstituted saturated alkyl, unsubstituted heteroalkyl, unsubstituted alkenyl, unsubstituted alkynyl, unsubstituted at least partially saturated cycloalkyl, unsubstituted ketoalkyl, unsubstituted hydroxyalkyl, unsubstituted aminoalkyl, —CH 2 —NR 3 R 4 , unsubstituted alkoxy, halo, unsubstituted haloalkyl, cyano, hydroxy, nitro, amino, unsubstituted carboxamido, —CONR 3 R 4 , —NR 3 R 4 , sulfonamido, —SO 2 NR 3 R 4 , —C(O)R 6 , —SR 5 , —SO 2 R 6 , —S(O)R 6 , —NR 6 C(O)R 7 , and —NR 6 SO 2 R 7, wherein R 3 and R 4 are selected from the group consisting of hydrogen, unsubstituted saturated alkyl, unsubstituted alkenyl, unsubstituted alkynyl, unsubstituted heteroalkyl, unsubstituted at least partially saturated cycloalkyl, unsubstituted hydroxyalkyl and imino-methylamino and optionally R 3 and R 4 may be taken together with the N atom to which they are attached to form a 5–7 membered ring; and R 5 , R 6 and R 7 are independently selected from the group consisting of hydrogen, unsubstituted saturated alkyl and unsubstituted saturated heteroalkyl; or a pharmaceutically acceptable salt thereof.